a b s t r a c t G-rich sequences in DNA and RNA have a propensity to fold into stable secondary structures termed G-quadruplexes. G-quadruplex forming sequences are widespread throughout the human genome, within both, protein coding and non-coding genes, and regulatory regions. G-quadruplexes have been implicated in multiple cellular functions including chromatin epigenetic regulation, DNA recombination, transcriptional regulation of gene promoters and enhancers, and translation. Here we will review the evidence for the occurrence of G-quadruplexes both in vitro and in vivo; their role in neurological diseases including G-quadruplex-forming repeat expansions in the C9orf72 gene in frontotemporal dementia and amyotrophic lateral sclerosis and loss of the G-quadruplex binding protein FMRP in the intellectual disability fragile X syndrome. We also review mounting evidence that supports a role for G-quadruplexes in regulating the processing or function of a range of non-coding RNAs. Finally we will highlight current perspectives for therapeutic interventions that target G-quadruplexes.
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Introduction
Strands of DNA or RNA that contain at least four stretches of two or more adjacent guanine nucleotides, for example G 2-5 X n G 2-5 X n G 2-5 X n G 2-5 X n , where X can be up to seven spacer nucleotides, are able to form structures termed G-quadruplexes. At the core of these arrangements are cation-coordinated quartets of guanine residues linked by Hoogsteen hydrogen bonds, as represented in Fig. 1A , and reviewed in detail in [1] [2] [3] . G-quadruplexes can either be intramolecular, forming from a single strand of DNA or RNA, or intermolecular, forming from either two or four separate nucleic acid strands Fig. 1B . G-quadruplexes can adopt either a parallel topology, in which the backbone of each nucleic acid strand of the G-quadruplex run in the same direction, or an anti-parallel topology in which the backbones run in opposing directions Fig. 1B . RNA G-quadruplexes are normally restricted to a parallel topology whereas DNA G-quadruplexes can form either type of structure. A marked preference in RNA for an anti glycosidic bond angle, is a consequence of steric constraints imposed by the C2 0 hydroxyl groups in RNA ribose sugars. This leads to a stable parallel topology. These quadruplexes can be further classified according to parameters such as the nucleotide sequence and size of spacer tracts, inclusion of bases other than guanine in the quartet structure, the overall molecular geometry of the quadruplex and the nature of the coordinating cations. We will review accumulating evidence of the occurrence of G-quadruplexes in vitro and in vivo and will provide examples of their roles within neurons both in normal and pathological states. We will then review recent studies that are revealing novel roles for G-quadruplexes in the regulation of the non-coding transcriptome, an exciting new area of investigation with potential implications for understanding G-quadruplex function genome-wide, and in the context of different diseases. Finally, we will provide an overview of the latest progress in therapeutic targeting of G-quadruplexes by small-molecule ligands. guanine-containing sequences are able to form oligomeric structures, as studied by NMR [6] and (ii) these structures are centrally coordinated by cations. Alkali-metal ions were shown to be able to stabilize the unfavourable electronic charge of the four oxygen atoms exposed in the centre of an individual G-quartet, showing a decreasing stability conferred by K + > Na + > Li + [3] . The ion selectivity is better explained by K + ions being larger than Na + or Li + , so they fit more effectively in between adjacent G-quartets [2] . Multiple supramolecular assemblies of G-quadruplex structures have been demonstrated by NMR and light scattering to occur in vitro. G-quartets formed from 5 0 -GMP can self-organize into columnar structures and multiple columns can also arrange in a cholesteric phase or in a hexagonal liquid-crystalline phase [7] .
DNA G-quadruplexes
Beyond these first in vitro biophysical studies on self-assembly of 5 0 -GMP, it was in a series of later studies in the 1980s that G-quadruplexes were suggested to be biologically functional structures. A key advance was the realisation that all chromosomal telomeric regions contain repetitive G-rich sequences suitable for quadruplex formation. These telomeric sequences have thus been extensively studied for their ability to form G-quadruplexes and have provided important structural and functional information. Sen and Gilbert [8] provided evidence that G-quadruplexes formed intermolecularly between pairs of chromosomes and proposed a model in which G-quadruplex formation drives chromatid pairing during meiosis. Sundquist and Klug [9] were amongst the first to show that telomeric repeats from Tetrahymena dimerize in a salt-dependent manner to adopt an antiparallel G-quadruplex arrangement, which may be important for telomere recombination. The first structural studies employed NMR of G-rich DNA oligonucleotides and demonstrated that they fold into a parallel G-quadruplex structure [10] . X-ray crystallographic studies further characterized the different topologies of the G-quadruplexes formed in vitro by short oligonucleotides. Haider et al. [11] showed by crystallography that the DNA telomeric d(G 4 T 4 G 4 ) 2 repeats from the ciliate Oxytricha form a K + -stabilized bimolecular G-quadruplex, in which two hairpins join together into an anti-parallel structure with thymidine loops at either end. Quite different is the conformation obtained for the human telomeric DNA d[AGGG(TTAGGG) 3 ], which in the presence of K + ions, was
shown to assume a parallel unimolecular G-quadruplex with fold-back TTA loops [12] , extending far away from the G-quartet core, thus providing potential binding sites for telomere interacting proteins. It differs fundamentally from the antiparallel folds found by NMR studies on various human telomeric sequences studied in dilute solution [13] . This structure was also substantially different from a previous study of a distinct Tetrahymena telomeric DNA repeat sequence of d(TGGGGT), obtained in the presence of Na + ions, which was shown to form a parallel four-stranded intermolecular G-quadruplex [14] .
RNA G-quadruplexes
Much less is known about the topology of RNA G-quadruplex structures, with a few exceptions. Deng et al. [15] determined the X-ray crystallographic structure at subatomic resolution of r(UGGGGU) 4 in the presence of Sr 2+ ions, and showed that it forms a parallel G-quadruplex with each unit stacking on one another with opposite polarity, resulting in a columnar arrangement. The human telomeric RNA G-quadruplex has a parallel topology both in the crystal and in solution, which is closely similar to the telomeric DNA G-quadruplex propeller-like arrangement [16, 17] . The CGG repeat within the 5 0 -untranslated region of the Fragile X syndrome gene FMR1 was modelled using a d(GCGGT 3 GCGG) oligonucleotide [18] . NMR showed that the sequence forms a G-quadruplex through dimerization of two symmetric hairpins held together by two canonical G-quartets in a sandwich-like structure with two middle G C G C Watson-Crick base paired quartets and with connecting T 3 loops at opposite sides. This demonstrated for the first time that G-quadruplexes can form a mixed assembly of Hoogsteen hydrogen bonded G-quartets and dimerized Watson-Crick G . C base-pairs.
Hybrid DNA:RNA G-quadruplexes and R-loops
When transcription occurs, the newly synthesised transcript still bound to the RNA polymerase holoenzyme can potentially form a heteroduplex structure pairing with the non-template DNA strand. This leads to formation of a DNA . RNA hybrid known as an R-loop, which in turn affects transcription [19] . When the DNA and RNA sequences involved in the R-loop formation contain two or more adjacent guanines, they can potentially fold into an intermolecular DNA:RNA hybrid G-quadruplex. A recent bioinformatics analysis found that putative DNA:RNA hybrid G-quadruplex (PHQs) are strongly biased towards the non-template DNA strand and are mainly enriched within 1 kb downstream of the transcription start site (TSS) [20] , consistent with their involvement in transcriptional regulation. PHQ formation requires as few as two G-tetrads instead of four or more as in canonical intramolecular G-quadruplexes and were present in more than 97% of human genes [21] . R-loops and hybrid G-quadruplexes have been documented to occur in many different contexts and have been ascribed different functions, such as a role in controlling immunoglobulin class switch recombination [22] , or the switch between mitochondrial genome transcription and replication [23] . More recently a role for R-loops has also been proposed in different neurodegenerative diseases such as those caused by repeat expansions in the C9orf72 [24, 25] and FMR1 [26, 27] genes.
Evidence for G-quadruplex formation in vivo
The studies described above clearly demonstrate the existence of G-quadruplexes in vitro. This section will focus on the smaller number of studies that also support their presence in vivo. Several independent lines of evidence support the existence and functional relevance of G-quadruplexes in vivo, which can be mainly summarized as (1) evidence of G-quadruplex specific helicases, (2) in vivo NMR, (3) G-quadruplex specific antibodies and (4) indirect functional evidence.
Evidence of G-quadruplex specific helicases
One of the earliest pieces of circumstantial evidence for the existence of G-quadruplex structures in vivo, came in 2002, when mutations in the dog-1 gene in Caenorhabditis elegans were shown to cause multiple recurrent deletions of genomic DNA at the 3 0 -end of polyguanine stretches [28] . DOG-1, which stands for ''deletions in guanine-rich DNA'', encodes for a G-quadruplex DNA helicase, which is essential for resolving long stretches of polyguanine, especially those containing more than 18 consecutive dG/dC. The gk10 null mutation, caused by a premature stop codon, leads to breakpoints either at the 5 0 -end of poly(dC) or at the 3 0 -end of poly(dG). The mechanism is compatible with a failure in lagging-strand DNA synthesis, which would require the DOG-1 helicase to unwind G-quadruplex structures that can readily form on the non-template DNA strand, during replication. The human homolog of DOG-1, called FANCJ/BRIP1, has also been shown to regulate progression of DNA replication through resolution of G-quadruplexes [29] , as cells deficient for FANCJ exhibit G-quadruplex DNA instability similarly to the C. elegans dog-1 mutant, caused by replication stalling at G-quadruplexes. Other eukaryotic DNA-RNA helicases have since been shown to be able to either specifically unwind G-quadruplexes or to resolve RNA:DNA hybrid R-loops. The Pif1 family of helicases, conserved from bacteria to humans, regulate DNA replication through G-quadruplexes, protecting the genome from DNA damage in the vicinity of these motifs, which are prone to breakage [30, 31] . A more recent study showed that Pif1 monomers anchored at the 3 0 -end of G-quadruplexes, are able to cyclically unwind DNA G-quadruplexes, extruding them into a loop one nucleotide at a time [32] . After a first cycle of activity and following G-quadruplex refolding, without dissociating from its site, Pif1 helicase is able to repeatedly unwind G-quadruplex DNA, even in the presence of G-quadruplex-binding drugs [32] . DHX36, also known as G4 resolvase 1 or RHAU, is another abundant DNA-RNA helicase able to strongly bind and resolve both DNA [33] and RNA G-quadruplex structures in mammalian cells [34] . A recent study offered a mechanistic view of how DHX36 works: markedly different from the highly processive activity displayed by Pif1 family helicases which remain stably attached to their substrates preventing them from refolding, DHX36 activity is unprocessive, as the helicase dissociates from the substrate after each ATP hydrolysis event [35] . These two types of mechanism suggest that different functions might be regulated through different G-quadruplex helicases, or they can simply target different categories of target genes.
The overrepresentation of G-quadruplexes near transcription start sites and the occurrence of transcription-induced formation of G-quadruplex structures strongly suggests that factors binding and resolving those structures might well be associated with the transcription apparatus. Recently two components of the general transcription factor TFIIH, XPD and XPB have been shown by chromatin immunoprecipitation-sequencing (ChIP-Seq) to be preferentially associated to G-quadruplex motifs along about 20% of human genes [36] . Particularly XPD acts as a G-quadruplex DNA helicase whereas XPB is a G4 DNA-binding protein, and both of them are crucial for coordinating DNA damage checks and repair mechanisms coupled to the opening of DNA during transcription [36] . DHX9/RNA helicase A represents an abundant cellular helicase unwinding RNA G-quadruplexes and R-loops [37] , much more efficiently than duplex DNA. By resolving those structures DHX9 has been suggested to contribute to transcriptional activation and to maintain genomic stability.
In cell-NMR
A recent approach called ''in cell-NMR'' has enabled the study of not only proteins but also nucleic acids directly in the eukaryotic environment [38] . G-quadruplex structures were directly determined with 13 C and 15 N NMR, by injecting different radiolabelled-oligonucleotides into Xenopus oocytes [39] .
G-quadruplex-specific antibodies
In a different approach to provide direct evidence of the in vivo occurrence of G-quadruplexes, the production of specific antibodies has been achieved, which enabled the direct imaging of the intracellular distribution of G-quadruplex structures in different cell types. A first study by Schaffitzel and colleagues [40] generated high-affinity single-chain antibody fragments (scFv) against the G-quadruplex d(T 4 G 4 ) from Stylonychia telomeres, by ribosome display from a human combinatorial antibody library. The Sty3 scFv was highly specific for parallel G-quadruplexes whereas a second scFv (Sty49) bound both parallel and anti-parallel G-quadruplexes. The latter antibody stained the ciliate macronucleus, a large nuclear structure containing genes necessary for vegetative growth, arranged in about 10 8 telomere-capped nanochromosomes, clearly demonstrating the occurrence of telomeric G-quadruplexes within this compartment. Furthermore, no specific staining was visible within the replication band, a region where chromosome and telomere replication takes place, suggesting that G-quadruplexes were resolved during replication [41] .
More recently another murine monoclonal antibody (1H6) was developed and showed a specific nuclear staining in human HeLa cells, which was sensitive to DNAse treatment and showed an increased intensity in response to increasing concentrations of the G-quadruplex stabilizing agent TMPyP4 [42] . An increased antibody staining was also observed in response to a deficiency of the G-quadruplex DNA specific helicase FANCJ, suggesting a prominent role for this helicase in unwinding DNA G-quadruplex motifs [42] . This study also showed that whereas G-quadruplexes in normal cells can be effectively unwound by helicase action, in those cancer cells where FANCJ is mutated it was significantly less effective. Biffi et al. [43, 44] developed a G-quadruplex specific antibody (BG4) that enabled them to visualize cytoplasmic RNA G-quadruplexes in human fibroblasts for the first time. Their conformation-specific antibody [43] labelled both nuclear and cytoplasmic foci, which were sensitive to either RNAse or DNAse treatment respectively, demonstrating that these foci represent bona fide RNA and DNA G-quadruplex structures. Furthermore the number of cytoplasmic RNA G-quadruplex foci increased when cells were treated for 24 h with CarboxyPyridostatin, a ligand specific for RNA G-quadruplexes [44] .
G-quadruplex structure-specific antibodies have also been used to show that G-quadruplexes modulate gene expression in vivo. Fernando et al. [45] expressed a single chain antibody selective for G-quadruplex DNA over double strand DNA (1HF) in HGC-27 human gastric carcinoma cells, and observed significant expression changes in large sets of genes, correlated with the presence of putative G-quadruplexes. Therefore, based on both in cell-NMR and G-quadruplex-specific antibodies generated by several independent groups there is mounting evidence to support the presence of physiologically relevant G-quadruplexes in vivo. G-quadruplex formation in vivo is also indirectly supported by evidence obtained in studies of G-quadruplex-binding proteins and the role of G-quadruplexes in non-coding RNA regulation, as discussed further below.
G-quadruplexes in neurological disorders
Two main categories of human diseases have shown an involvement of G-quadruplex motifs: cancers and neurological disorders. This suggests G-quadruplexes can play a physiological role that is altered in disease states. A physiological role for G-quadruplexes is supported by the non-random genomic distribution of G-quadruplex motifs in the human genome [2, 46, 47] , as well as by the enrichment of G-quadruplex motifs within microsatellites and regulatory elements in particular categories of genes [48] [49] [50] . G-quadruplexes have been implicated in neurological diseases via two distinct mechanisms: (i) through expansions of G-rich sequences found to be causal of disease that are predicted to form G-quadruplexes, and (ii) by mutations that affect the expression of G-quadruplex binding proteins. These mechanisms are best described for repeat expansions in C9orf72 and loss of the fragile X mental retardation protein (FMRP) respectively, which we will focus on here. In addition, several other neurodegenerative disease genes contain G-rich repeat expansions that may also lead to G-quadruplex formation (Table 1) . Finally, the processing of specific G-quadruplex-containing tRNAs has been shown to be neuroprotective (Table 1 ) and this will also be discussed.
Expansions of G-quadruplex-forming repeats in C9orf72 causes FTD and ALS
Amyotrophic lateral sclerosis (ALS) causes progressive muscle weakness and spasticity due to motor neuron degeneration. Frontotemporal dementia (FTD) manifests with changes in behaviour, language and personality, caused by degeneration of neurons in the temporal and frontal lobes of the brain. Accumulating evidence suggests that these two diseases form a continuum, with a spectrum of phenotypic variants of the same pathological process, which involves altered homeostasis of key master regulators like the DNA-RNA binding proteins TDP-43 and FUS [74, 75] .
Further support to the common pathogenic process involved in ALS-FTD came in 2011 with the discovery that sporadic and familial cases of both disorders are caused by an expansion of a GGGGCC (G 4 C 2 ) repeat within the first intron of the C9orf72 gene [55, 56] ( Fig. 2A) , termed C9FTD/ALS. Indeed the C9orf72 (G 4 C 2 ) repeat expansion is now known to be the most common genetic cause of both FTD and ALS [76] . Healthy individuals carry an average of 2 repeats, with 90% having 8 or less [77] . In ALS and FTD patients the G 4 C 2 repeats range between $500 and several thousand units [78, 79] . We have shown that G 4 C 2 repeat RNA folds into a very stable parallel G-quadruplex [51] (Fig. 2B) , which was confirmed by other groups [52, 54] . Furthermore, Reddy et al. [54] showed that r(G 4 C 2 ) but not r(G 2 C 4 ) RNA repeats form both uni-and multimolecular G-quadruplexes. Because multimolecular-G-quadruplexes formed more efficiently with longer repeats, the authors hypothesized that RNA-RNA interactions mediated through G-quadruplexes might help explain transcript aggregation and RNA foci formation in C9FTD/ALS [54] . More recently it was demonstrated that d(G 4 C 2 ) repeats also give rise to a mixed parallel-antiparallel G-quadruplex topology at the DNA level [52, 53] . In combination, these findings have profound implications for understanding disease mechanism, implicating a potential role of G-quadruplexes in C9orf72 both at the DNA and RNA levels.
C9orf72 repeat RNAs sequester specific proteins
Several studies have implicated G-quadruplexes in various aspects of cellular regulation and maintenance, ranging from recombination to transcription, splicing, RNA localization and translation [2, 80, 81] . Haeusler and colleagues [52] showed that expansion of G 4 C 2 repeats in C9orf72 lead to formation of DNA . RNA hybrids, known as R-loops, which stall RNA polymerase, leading to lower levels of full-length C9orf72 transcripts and causing accumulation of abortive transcripts containing G-quadruplex structures. The same repeat-containing transcripts were shown to bind and sequester nucleolin in a conformation-dependent manner [52] (Fig. 2C) . Nucleolin was mislocalized in patient-derived cells carrying the expansion, and nucleolar function was impaired in the same patient cells [52] (Fig. 2C) . Nucleolar stress was recapitulated in wild-type cells overexpressing expanded G 4 C 2 repeats, suggesting that an impairment in ribosomal RNA biogenesis and other nucleolar functions might occur early in C9FTD/ALS [52] . These results illustrated the importance of the G-quadruplex conformation of C9orf72 DNA/RNA expanded repeats as a determinant of the pathogenic mechanism in disease. RNA foci composed of sense and antisense G 4 C 2 repeat RNA have been found by several independent studies in post-mortem brain regions and spinal cord of C9FTD/ALS patients [56, [82] [83] [84] [85] [86] [87] [88] (Fig. 2C) . Using in vitro biochemical assays, G 4 C 2 RNA repeats were shown to sequester several D) . Particularly, arginine-rich DPR proteins, recently shown to confer neurotoxicity [98] , also accumulate in the nucleolus [99] , further contributing to nucleolar stress.
other proteins including splicing factors (hnRNPA1, hnRNPH, SC35), the mRNA export receptor ALYREF, the single strand DNA binding protein Pur-alpha, the RNA-binding protein hnRNPA3 and the RNA editing factor ADARB2, which have been extensively reviewed in [89] . Collectively these studies suggest that expanded G-quadruplex tracts in C9orf72 may cause disease through an RNA gain of function mechanism [90] .
C9orf72 repeats undergo repeat-associated non-ATG translation
A major advance in the repeat expansion field came in 2011 with the discovery that expanded repeat sequences can be directly translated through a non-canonical mechanism known as repeat-associated non-ATG (RAN) translation. This phenomenon, originally described for the CAG repeats present in human spinocerebellar ataxia type 8 (SCA8) and myotonic dystrophy type 1 (DM1) [91] , was more recently shown to occur on C9orf72 G 4 C 2 expanded repeats [87, 92] and on fragile-X tremor ataxia syndrome CGG repeats [93] . The C9orf72 expanded repeats are subject to RAN translation giving rise to dipeptide repeat proteins (DPR) in all possible frames [60, 61, 86, 94, 95] , on both strand orientations, and independently from translation of the host protein-coding gene (Fig. 2D ). All DPR proteins give rise to neuronal cytoplasmic inclusions (Fig. 2D ) in patient brain [60] [61] [62] [63] [64] [65] , and frequently colocalize with p62-positive, TDP-43 negative inclusions [64, 65, 96, 97] . Expression of DPRs in Drosophila neurons [98, 99] or primary rodent neuronal cultures [96, 97] causes profound toxicity, implicating DPRs in disease pathogenesis. This raises the critical as yet unanswered question whether the r(G 4 C 2 ) G-quadruplexes structures play a role in the initiation or inhibition of RAN translation. This possibility is supported by the known role of G-quadruplexes in affecting translation as discussed in the sections below. DPRs are also generated from r(C 4 G 2 ) antisense transcripts, whose structure is not yet determined, but could form G-quadruplexes of lower stability, characterized by only two G-tetrads. It is also possible for both sense and antisense repeats that other alternative secondary structures potentially in equilibrium with G-quadruplexes, might play a role in controlling RAN translation. Indeed the first description of RAN translation suggested hairpin structures may mediate translation [91] . In conclusion, the G 4 C 2 repeat in C9orf72 could play a role in disease pathogenesis both at the level of RNA toxicity through sequestering RNA-binding proteins and potentially at the protein level through either facilitating or hindering RAN translation.
FMRP is a G-quadruplex binding protein implicated in neurological disease
In 1991 Verkerk et al. [100] identified the gene responsible for Fragile X syndrome (FXS), called Fragile X Mental Retardation gene 1 (FMR1, shown in Fig. 3A) . FXS is a common form of inherited intellectual disability (ID), with an incidence of 1 in 5000 males [101] . Postmortem examination revealed that FXS patients' neurons have dense, immature dendritic spines [71] . Most cases of FXS are caused by a large expansion of a CGG repeat in the 5 0 -UTR of FMR1, which causes methylation and silencing of FMR1 and the lack of FMRP protein expression [102, 103] (Fig. 3B) . FMRP is a widely expressed protein enriched in brain and testes [77] and is a well characterized G-quadruplex binding protein. Its involvement in disease has been hypothesized to be linked to alterations in protein translation and alterations in RNA localization. In neurons FMRP is mainly cytoplasmic and localised in the cell body, dendrites and synapses [104, 105] where it is translated in response to neurotransmitter release [106] . FMRP is a sequence-specific mRNA-binding protein that represses translation of a subset of dendritically localized mRNAs, corresponding to about 4% of all brain mRNAs [107] . About 400 different mRNAs have been found to be potential targets of FMRP [108, 109] , although only 14 of these targets have been experimentally validated [60] . FMRP recognizes specific secondary structures in its target mRNAs, the most frequent of which is a G-quadruplex [110] . FMRP binds G-quadruplexes in vitro through its C-terminal RGG box domain [111] (Fig. 3C) , and most of its validated targets contain a putative G-quadruplex motif in their mRNA. Arginine methylation of the RGG box domain reduces affinity of FMRP for its G-quadruplex target mRNAs [111] . Biochemical assays confirmed that G-quadruplexes mediate binding of FMRP to its own Fmr1 mRNA (due to a G-quadruplex in exon 13, outside of the CGG repeat see Fig. 3A ) [112] , as well as to MAP1B [113] and Sema3F [114] . FMRP coimmunoprecipitates with a G-rich element in amyloid precursor protein (APP) mRNA [115] , and represses its translation. FMRP has been shown to bind and regulate stability of the post-synaptic mRNA PSD-95 [116] , although it is not clear whether its binding is entirely mediated through the PSD-95 G-quadruplex motif.
FMRP binding to RNA G-quadruplexes directly affects translation
FMRP usually inhibits translation of its target mRNAs by blocking initiation of translation [117, 118] (Fig. 3D) , causing ribosome stalling [119] (Fig. 3C) , interacting with the RNAi pathway [120] [121] [122] (Fig. 3D) , or a combination of the three. Particularly intriguing is the hypothesis that FMRP binding to G-quadruplexes may stabilize their structures and provide a steric block to ribosome elongation. In response to synaptic activation FMRP is dephosphorylated leading to release from its target mRNAs and subsequent derepression of translation of specific synaptic proteins, allowing their expression to occur locally at specific times and thus having a critical role in dendritic local protein synthesis and synaptic plasticity [123, 124] . In the absence of FMRP, mGluR-mediated Long Term Depression (mGluR-LTD) signaling is overactive, and synaptic plasticity is reduced [125] . This molecular dysregulation is the major cause of the cognitive deficits observed in FXS patients [126] . FMRP has been also reported to bind to a subset of its target mRNAs through either U-rich stretches [127] or a tripartite stem-loop structure known as Sod1 stem loops interacting with FMRP (SoSLIP) [128] . SoSLIP interacts with FMRP's C-terminal region, encompassing the RGG box, and competes for binding with the G-quadruplex structure [128] . Surprisingly both SoSLIP and U-stretches motifs when bound to FMRP lead to translation activation of the host target gene [127, 128] . This suggests that FMRP-RNA interactions will either activate or repress translation depending on the type of structure FMRP is binding to, it's proximal or distal position, and its phosphorylation status. Overall, all these studies on G-quadruplex-FMRP interactions strongly highlight the importance of putative G-quadruplex motifs in the regulation of local translation of hundreds of key mRNAs in neuronal cells and its dysregulation as one major patho-mechanism in FXS.
FMRP binding to RNA G-quadruplexes is required for neuronal trafficking of specific mRNAs
A recent study proposed a role for G-quadruplex RNA structural elements as a signal for neurite mRNA targeting. Subramanian et al. [129] found that around 30% of well-known dendritic mRNAs contain a G-quadruplex motif in their 3 0 -UTR and this motif is necessary and sufficient to confer neurite localization to GFP reporters containing the 3 0 -UTR of either PSD-95 or CaMKIIa in transfected mice primary cortical neurons [129] . This finding raises the intriguing possibility that G-quadruplexes formed by repeat expansion in neurological diseases may lead to altered localization of the mRNAs in which they reside.
CGG repeats in FMR1 can form DNA G-quadruplexes
Intriguingly there is evidence that the FMR1 CGG DNA repeats can readily form both hairpins [130] [131] [132] [133] and a parallel bimolecular G-quadruplex structure [18, [61] [62] [63] 0 -UTR and a G-quadruplex motif within exon 13 [179] . (B) Wild-type alleles with less than 54 CGG repeats are transcribed at a basal level and result in normal FMRP protein levels. Premutation carriers bearing an intermediate number of repeats (55-200 units) , which is associated with fragile X tremor ataxia (FXTAS) in males or fragile X-related primary ovarian insufficiency (FXPOI) in females, exhibit increased FMR1 transcription, but slightly diminished FMRP translation [180] . FXTAS may be caused by RNA toxicity, toxic RAN translation products, or both. Full expansion with more than 200 CGG repeats, results in abolishment of FMR1 transcription and translation due to an induction of DNA methylation and epigenetic heterochromatin modifications on fully expanded alleles. Lack of FMRP leads to the development of fragile X syndrome. FMRP binds to parallel RNA G-quadruplexes in several target transcripts, mainly within 3 0 -UTRs. FMRP, in its phosphorylated state, is able to repress translation either alone by stalling ribosomes in the elongation stage (C), or recruiting other co-factors such as the co-repressor CYFIP or miRNA-loaded RISC (D), and preventing assembly of a ternary complex between cap-bound initiation factors eIF4E and eIF4G and the poly(A)-binding protein (PABP). (E) FMRP regulates trafficking of hundreds of mRNA from the cell body to the dendrites. Phosphorylated FMRP binds to Gquadruplex in dendritic transcripts, maintaining them in a repressed state, to prevent their premature translation during trafficking. Upon stimulation of metabotropic glutamate receptors (mGluR), FMRP is dephosphorylated on Ser499 and polysomes are released from repression, to allow local synaptic translation to occur [126] .
expansions of the d(CGG) repeat allow for its transcription, although resulting in the production of a lower level of FMRP protein [60] .
A neuroprotective role for G-quadruplex containing tiRNAs
G-quadruplexes have been shown to be involved not only in causing neurodegeneration but also in being able to confer neuroprotection. Particularly interesting is the case of the angiogenin (ANG) gene and its target RNAs. ANG possesses ribonuclease A activity that is responsible for processing of tRNA transcripts [134, 135] , leading to translation inhibition. Rare missense mutations in ANG result in loss of either ribonucleolytic activity or nuclear translocation, or both functions, and have been suggested to cause ALS [136] and Parkinson's disease (PD) [137] . Stress signalling can activate ANG ribonuclease activity leading to cleavage of tRNAs within anticodon loops, generating tRNA-derived stress-induced fragments (tiRNAs) [71, 72] . Sprcific tiRNA fragments (tiRNA Ala , tiRNA Cys ) inhibit translation initiation by displacing the interaction of the initiation factors eIF4G/eIF4A or eIF4F with cellular transcripts. This sequence of events is neuroprotective for cells under stress. A 5 0 -terminal G-quadruplex forming oligomeric G-rich motif within the tiRNA is required for the tiRNA-mediated protein synthesis inhibition and subsequent neuroprotective stress granule (SG) assembly [72, 73] . Similarly DNA analogs of tiRNA Ala and tiRNA Cys enter cells, inhibit translation, promote formation of SGs, and confer neuroprotection to motor neurons exposed to stresses such as excitotoxicity and serum withdrawal [73] . However, it should be noted that prolonged inhibition of translation ultimately becomes neurotoxic in several neurodegenerative disease paradigms [138, 139] indicating that translation control must be delicately balanced to promote neuronal survival.
Novel roles for G-quadruplexes in the regulation of noncoding RNAs
The human genome contains about 376 000 different potential G-quadruplex-forming sequences, which follow a non-random distribution [48, 49] . G-quadruplexes are enriched at telomeres where they inhibit the activity of the telomerase reverse transcriptase, and regulate telomere length through the action of specific G-quadruplex-binding proteins. G-quadruplexes are particularly enriched in human promoter regions [140] , where they contribute to the regulation of transcription. Although at a genome wide level G quadruplexes are not increased in 3 0 UTRs, when considering neuronal transcripts that are transported to neuronal processes, an enrichment in G-quadruplexes is found. A higher frequency of G-quadruplexes is observed in certain categories of genes like ribosomal DNA repeats [141] , immunoglobulin genes and oncogenes in comparison to tumor suppressors [142] . Less is known about the occurrence of G-quadruplex structures in the non-coding transcriptome. In Table 2 we summarize current studies that are starting to reveal novel roles for G-quadruplexes in the function and biogenesis of different classes of human non-coding RNAs (ncRNAs), and show their potential involvement in disease. Considering the abundance of studies on the role of G-quadruplexes in telomeric repeat RNA (TERRA) and Telomerase RNA component (TERC) ncRNAs, reviewed elsewhere [80, 143] , we will focus on other classes of ncRNAs, only recently investigated.
G-quadruplexes in long non-coding RNAs
A recent bioinformatics survey mapped the distribution of G-quadruplexes in human ncRNAs of various sizes [144] . It was found that 749 unique ncRNAs in the human genome (0.59% out of 126 406 ncRNAs annotated in the hg18 human genome assembly as reported in UCSC genome browser) are predicted to have at least one G-quadruplex. Particularly, long non-coding RNAs (lncRNAs) ranging from 200 to 300 nucleotides (nt) in size are enriched in G-quadruplex motifs, especially those with single or dinucleotide loops, suggesting that lncRNAs may form highly stable G-quadruplex structures that regulate their functions in vivo [144] . Considering the pervasive transcription that leads to expression, in a very tissue-specific manner, of a multitude of lncRNAs in the human genome, the presence of G-quadruplexes, in lncRNA transcripts or in their cis-regulatory elements, might have important implications for their in vivo regulation. Amongst the rapidly growing list of lncRNA online resources, the LncRNome database allows users to search for the occurrence of specific sequence motifs, such as G-quadruplex forming sequences, within their transcripts (http://genome.igib.res.in/lncRNome/).
G-quadruplexes in microRNAs
MicroRNAs (miRNAs) represent another important category of ncRNAs with roles in controlling development, differentiation and homeostasis. Mature miRNAs are 18-24 nt in size, but are initially transcribed by RNA polymerase II into a primary transcript (pri-miRNA) several kb in length. Biogenesis of the majority of miRNAs follows a ''canonical pathway'' composed of two distinct nuclear and cytoplasmic events. Processing of pri-miRNAs takes place within the nucleus, through an endonucleolytic cleavage by the RNAse III Drosha [149] , as part of the Microprocessor complex composed also of the DiGeorge syndrome critical region gene 8 (DGCR8) protein, that facilitates the recognition of a 2 nt 3 0 -overhang and a stem of $33 bp within the pri-miRNA [150] (Fig. 4A) . Drosha cleaves the substrate at $11 bp from the base of the stem, thereby releasing a small hairpin termed a pre-miRNA [151] . The pre-miRNA hairpin is then bound by the nuclear export factor Exportin-5 in complex with the GTP bound form of the cofactor Ran and released into the cytoplasm [152] . Once in the cytoplasm, the pre-miRNA hairpin is further cleaved by Dicer into $22 nt miRNA duplexes, and loaded onto an Argonaute (Ago) [80] protein, generating the effector RNA induced silencing complex (RISC) [153, 154] . One strand of the duplex remains loaded onto Ago as a mature miRNA (the so called guide strand, or miRNA), whereas the other strand (the passenger strand or miRNA ⁄ ) is usually degraded by the endonucleolytic activity of Ago proteins [155] . Strikingly, 126 human miRNA genes (about 7% of the human miRNAs reported in mirBASE when the study was published) are predicted to contain putative G-quadruplex motifs in their promoters [156] (http://tubic.tju.edu.cn/greglist), suggesting G-quadruplexes could play a role in regulating the expression of these miRNAs (Fig. 4A) . Furthermore, G-quadruplexes are found not only within miRNA promoters but also within the miRNA transcript. In a recent study Arachchilage and colleagues [145] observed that 298 out of 1881 human pre-miRNAs annotated in mirBASE (release 21, June 2014) contain potential G-quadruplex motifs within their transcript, with a high predictive score. Since canonical stem-loop structures represent a universal feature present in all known pre-miRNAs, essential for their maturation, the authors hypothesized that G-quadruplexes might co-exist in equilibrium with stem-loop structures and thus affect stem-loop processing by Dicer. They focused on pre-mir 92b, a miRNA involved in the development of intermediate cortical neuron progenitors [157] that is also responsible for reducing Smad3 expression in glioblastomas [158] . By RNAse T1 mapping, gel shift assay and CD spectroscopy, pre-miRNA 92b was shown to be in equilibrium between a stem-loop and a G-quadruplex structure, in a K + ion dependent manner [145] . The G-quadruplex, in the presence of potassium, inhibited Dicer-mediated cleavage in an in vitro maturation assay (Fig. 4C) , which did not occur in presence of lithium. G-quadruplex structure formation also inhibited maturation of miRNA-92b and target silencing in cells [145] , providing strong evidence of the in vivo relevance of the G-quadruplexes in regulating miRNA function. Another recent study [146] highlighted the importance of G-quadruplexes in the reversible inhibition of a target gene by miRNA-125a. MiRNA-125a has been shown to be critically involved in regulating the local translation of the post-synaptic density protein PSD-95, one of the dendritic mRNA targets of FMRP [159] . A complex between FMRP, Argonaute2 (AGO2) and mir-125a assembles on the PSD-95 3 0 -UTR when FMRP is phosphorylated on Ser499, leading to silencing of PSD-95 protein in dendrites [159] (Fig. 3B) . In response to mGluR signalling, FMRP is dephosphorylated and releases AGO2 from the complex leading to derepression of PSD-95 translation [159] . The miR-125a binding site on PSD-95 mRNA is embedded in the G-rich region bound by FMRP and predicted to adopt one or more G-quadruplex structures (Fig. 4B ). Stefanovic and colleagues [146] found that the miRNA-125a target region folds into alternate parallel G-quadruplex conformations, which coexist in equilibrium. Only one G-quadruplex conformation leaves the complete miRNA binding site exposed as a single strand region. MiRNA-125a is able to target the PSD-95 3 0 -UTR complementary region through canonical Watson-Crick base-pairing, leaving intact a distal G-quadruplex structure [146] (Fig. 4B) . Because FMRP is able to bind G-quadruplex motifs [110] , the spatial proximity of the distal G-quadruplex next to the miRNA-125a seeding region might offer a plausible explanation for the FMRP-mediated assembly of the RISC complex responsible for miRNA-125a guided PSD-95 silencing. Stefanovic et al. [146] provide evidence suggesting a novel mechanism for alternative G-quadruplex structures being able to regulate accessibility of miRNAs to their targets.
More speculatively, it is also possible that G-quadru plex-mediated regulation of miRNA biogenesis plays a role in the pathogenesis of neurodegenerative disease. Specifically, expansion of putative G-quadruplex-forming GGCCTG repeats in the first intron of the NOP56 gene has been found in familial cases of spinocerebellar ataxia type 36 (SCA36). Strikingly, repeat expansion does not result in any change of NOP56 expression, splicing or its normal localisation to nuclear Cajal bodies in patient-derived cells, suggesting that haploinsufficiency is unlikely to explain the SCA36 phenotype [64] . Interestingly, the authors reported that the expanded GGCCTG repeat induced a significant change in the expression of both precursor and mature Mir-1292, located just 19 bp downstream of the repeat, and proposed that this might lead to upregulation of glutamate receptors in particular cell types, resulting in compromised signal transduction and excitotoxicity [64] . One possibility is that the GGCCTG repeat forms G-quadruplexes that impact Mir-1292 transcription, however, there is currently no direct evidence to support G-quadruplex formation.
G-quadruplexes in PIWI-interacting RNAs
A separate class of small non-coding RNAs, known as PIWI-interacting RNAs (piRNAs) were recently shown to have G-quadruplex motifs in their transcripts [147] (Fig. 5A) . Mature piRNAs are 23-30 nucleotide long RNAs that bind to PIWI proteins to form PIWI-ribonucleoprotein particles (piRNP), which are primarily involved in the epigenetic silencing of transposons in the germline of metazoans, as extensively reviewed in [160] . More recently a subset of piRNAs have been found that are also expressed in somatic cells [161] and strikingly in the central nervous system of Aplysia [162] , Drosophila melanogaster [163] and in mouse hippocampus [164] . Primary piRNAs are produced in a stepwise process. A first endonucleolytic cleavage, most likely mediated by PLD6, generates piRNA precursor intermediate fragments (PPIFs), which are loaded onto PIWI proteins that stabilize their 5 0 -ends [165, 166] (Fig. 5B) . The second step is 5 0 -to-3 0 exonucleolytic trimming by an as yet unidentified nuclease [167] . Precursor piRNA trimming proceeds until it is sterically hindered by the loaded PIWI proteins, and it is functionally coupled with 2 0 -O methylation at the 3 0 -end by Hen1 [168] . Recently another protein, the RNA helicase MOV10L1 was found to mediate an early step in the piRNA biogenesis [169] . MOV10L1 selectively binds to G-quadruplex motifs within precursor piRNAs and resolves them in an ATP-dependent manner, to render their structure accessible to the endonuclease which catalyzes the first step of piRNA processing to generate PPIF intermediate fragments [147] (Fig. 5B) . G-quadruplexes may therefore act to regulate piRNA processing.
Therapeutic approaches targeting G-quadruplexes in neurodegenerative diseases
Current strategies to tackle neurodegenerative diseases linked to expanded G-quadruplexes include antisense-mediated interventions and small-molecule based approaches. These approaches are especially suitable in the case of diseases with a gain-of-function mechanism, as has been proposed for C9orf72 [90] , as by targeting the primary defect, knowledge of the downstream pathogenic mechanisms are not required. Antisense oligonucleotides (ASOs) targeting C9orf72 RNA either within or outside the G-quadruplex forming GGGGCC repeat region have successfully lowered toxicity in cellular models of C9orf72 repeat expansion [83, 84, 88] . ASOs have also been used previously to restore a normal phenotype in other neurodegenerative diseases characterized by gain-of-function mechanisms without involvement of G-quadrup lexes [170] [171] [172] [173] .
The presence of expanded G-quadruplexes in specific neurological disorders offers a second approach that utilises small-molecule ligands directly targeting the specific G-quadruplex structure involved. Over one thousand different G-quadruplex ligands have Fig. 4 . (A) G-quadruplexes can affect the miRNA biogenesis pathway at different stages: about 23% of miRNAs contain putative G-quadruplexes in their promoters that can prevent their transcription by stalling RNA polymerase II. G-quadruplex-specific helicases are required to resolve G-quadruplexes upstream of miRNA genes, leading to production of primary microRNA transcripts (pri-miRNA). Pri-miRNAs are processed in the nucleus by the Microprocessor complex, composed of DGRC8 and the RNAse III Drosha, which cleaves at the base of the stem, generating a $33 bp pre-miRNA. After being exported into the cytoplasm by Exportin-5 bound to the Ran-GTP cofactor, premiRNAs are normally processed near the loop region by DICER in complex with the double strand RNA-binding domain (dsRBD) protein TAR RNA-binding protein (TRBP). Following Dicer processing, the RNA duplex is released and subsequently loaded onto an Argonaute protein (AGO1-4), which is part of the RNA-induced silencing complex (RISC). (B) Alternative G-quadruplex conformations within the 3 0 UTR of a miRNA target can also regulate accessibility of the RISC complex to their target region on the mRNA, as exemplified by miRNA-125a targeting the post-synaptic density 95kDa (PSD-95) 3 0 -UTR. Phosphorylated-FMRP recognizes specific G-quadruplex structures and mediates recruitment of the RISC complex, establishing translational repression. In the conformation on the left hand side the miRNA-125a target sequence (orange) is within the first G-quadruplex making it inaccessible to the RISC. Binding of phosphorylated FMRP to the second G-quadruplex is compatible with an alternative conformation in which the miRNA-125a binding site is outside of the first G-quadruplex, allowing access [146] . (C) Some pre-miRNAs, can alternatively fold either into a canonical stem-loop or into a Gquadruplex structure, in a potassium ion-dependent manner. G-quadruplexes within pre-miRNAs inhibit DICER-mediated maturation as well as miRNA loading onto the RISC, as exemplified by pre-miRNA-92b [145] .
been reported to date, represented by a broad range of different chemotypes, generally rich in aromatic rings that enable stacking with the planar terminal tetrads, as exemplified by the crystal structure of the human telomeric G-quadruplex in complex with the ligand BRACO19 [174] . One potential issue for this approach is whether G-quadruplex-binding ligands can achieve sufficient specificity. This implies that each small-molecule could potentially recognise a unique G-quadruplex conformation in the human genome. G-quadruplexes present variation in their primary sequence, loop length, nucleic acid strand stoichiometry and orientation and thermodynamic stability, suggesting a high probability of structural uniqueness. While structural studies provide evidence that this is likely to be the case, to date no ligands have been reported to have 100% specificity for a single G-quadruplex sequence 0 -to-3 0 direction toward the endonuclease. MOV10L1 helicase activity recognizes and resolves RNA secondary structures like G-quadruplexes, facilitating cleavage that creates piRNA precursor intermediate fragments (PPIFs). Mili binds the newly formed PPIFs, and both are released from MOV10L1. Mili preferentially binds and stabilizes PPIFs with 5 0 U; this is followed by 3 0 end trimming and 2 0 -O methylation, resulting in mature piRNAs. This process may repeat as MOV10L1 in pICL continues piRNA precursor translocation. Piwi-loaded piRNAs enter a cycle of amplification in granular structures in the cytoplasm, where transposon element (TE) transcripts bound to Miwi2 are specifically cleaved after base-pairing with Mili-bound piRNAs, as represented for the ''ping-pong'' cycle taking place in mouse spermatogonia [160] . [175, 176] . A useful resource of information listing most of the known G-quadruplex-binding ligands can be consulted online at www.g4ldb.org.
Recently two studies have explored this strategy of conformation-dependent ligands to tackle C9FTD/ALS. A recent paper by Zamiri et al. [177] found that TMPyP4, a cationic porphyrin known to bind G-quadruplexes is able to bind the C9orf72 G 4 C 2 repeat and distort its structure, diminishing its interactions with hnRNPA1 and SF2 proteins. This study established an important proof of principle that G-quadruplex-binding small-molecule ligands can be used to target the expanded C9orf72 G 4 C 2 repeats [177] . Similarly Su and colleagues [178] identified lead small-molecules targeting the G 4 C 2 repeats that were able to decrease both RAN translation and RNA foci in both transfected cultured cells and neurons derived from patients carrying the repeat expansion. These studies indicate that small molecules targeting G 4 C 2 RNA repeats are a viable therapeutic strategy.
Conclusion
G-quadruplexes have long been studied in vitro. Convincing evidence now supports their existence in vivo, and furthermore that they play important roles both in the normal physiology of the cell and in disease. The emerging role of G-quadruplexes in neurodegenerative diseases highlights their importance to normal neuronal function and also raises possibilities for therapeutic intervention. Many studies are bringing to light a multitude of different mechanisms through which ncRNAs operate within cells and cause dysfunction in disease; mounting evidence for a link between G-quadruplexes and ncRNAs promises that this will be an exciting future area of investigation.
